Related Experiment Video
Updated: Dec 29, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Tumor immune microenvironment in head and neck cancers
Samantha M Y Chen1, Alexandra L Krinsky1, Rachel A Woolaver1
1Department of Immunology and Microbiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Head and neck squamous cell carcinomas (HNSCCs) feature an immunosuppressive tumor microenvironment (TME). Understanding immune cell roles in HNSCC TME is key to developing effective immunotherapies.
Area of Science:
- Oncology
- Immunology
Background:
- Head and neck cancers, predominantly squamous cell carcinomas (HNSCCs), are aggressive and globally prevalent.
- The tumor microenvironment (TME) is crucial, comprising diverse cells interacting within tumor networks.
- Immune cells, both innate and adaptive, are vital for immune surveillance and tumor growth control in HNSCC.
Purpose of the Study:
- To elucidate the roles of various immune cell subsets within the HNSCC tumor microenvironment.
- To explain how these immune cells contribute to an immunosuppressive TME in head and neck cancers.
- To summarize recent advancements in immunotherapeutic strategies for treating HNSCC.
Main Methods:
- Review of scientific literature on HNSCC immunology and tumor microenvironment.
- Analysis of immune cell subsets and their interactions within the HNSCC TME.
- Synthesis of current knowledge on immunotherapeutic approaches for HNSCC.
Main Results:
- Identified diverse immune cell populations within the HNSCC TME.
- Characterized the contribution of these immune cells to an immunosuppressive tumor microenvironment.
- Highlighted the importance of immune surveillance and control in HNSCC progression.
Conclusions:
- A comprehensive understanding of immune cell functions in the HNSCC TME is essential.
- Targeting factors influencing HNSCC tumorigenesis and progression may lead to novel immunotherapies.
- Further research into the HNSCC TME can improve treatment efficacy for patients.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy